December 31, 2014

Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA

Our NIPT validation in high risk pts for DS, T18, T13, SCAs, and fetal sex • Overall, there were 137 pregnancies with trisomy 21, 39 with trisomy 18, and 16 with trisomy 13.  • Trisomy 21: sensitivity was 100%, specificity >99%, False positive rate 0.1%, PPV of 97.9%.  • 3 false negatives T18 and 2 false negatives T13 • No false positive te